Molecular Partners AG (SWX:MOLN)
Switzerland · Delayed Price · Currency is CHF 3.050
-0.070 (-2.24%)
Apr 1, 2026, 5:30 PM CET
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of 114.11 million as of April 1, 2026. Its market cap has decreased by -16.14% in one year.
Market Cap
114.11M
Enterprise Value
24.69M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.05
Market Cap Chart
Since November 4, 2014, Molecular Partners AG's market cap has decreased from 426.07M to 114.11M, a decrease of -73.22%. That is a compound annual growth rate of -10.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 114.11M | -9.87% |
| Dec 30, 2025 | 126.60M | -15.41% |
| Dec 30, 2024 | 149.66M | 32.42% |
| Dec 29, 2023 | 113.02M | -43.62% |
| Dec 30, 2022 | 200.48M | -65.16% |
| Dec 30, 2021 | 575.43M | -4.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 835.00M |
| Basilea Pharmaceutica AG | 646.54M |
| Newron Pharmaceuticals | 308.17M |
| Santhera Pharmaceuticals Holding AG | 211.40M |
| BioVersys AG | 175.44M |
| Xlife Sciences AG | 118.24M |
| EvoNext Holdings | 5.91M |
| Addex Therapeutics | 5.13M |